Latest Schedule 13G passive stakes

Jane Street Group, LLC, Jane Street Capital, LLC, and Jane Street Global Trading, LLC have collectively reported beneficial ownership of 5.0% of IP Strategy Holdings, Inc. common stock.

New Enterprise Associates entities and associated individuals have filed a joint Schedule 13G, reporting beneficial ownership of Coursera, Inc. common stock.

Glazer Capital, LLC and Paul J. Glazer have reported beneficial ownership of 2,685,520 shares, representing 5.49% of BioLife Solutions, Inc.'s common stock.

Manchester Management entities and individuals James E. Besser and Morgan C. Frank have collectively reported beneficial ownership of 7.4% of Alpha Cognition Inc.'s common stock.

SCWorx Corp. has filed a Schedule 13G detailing beneficial ownership changes, with Intracoastal Capital LLC, Mitchell P. Kopin, and Daniel B. Asher collectively holding 9.1% of common stock.

Perceptive Advisors LLC, along with affiliated entities and Joseph Edelman, has reported beneficial ownership of 5.3% of Nurix Therapeutics, Inc. common stock.

Hawk Ridge Capital Management LP and its affiliates have reported beneficial ownership of 5.1% of Array Digital Infrastructure, Inc.'s common shares, totaling 2,728,548 shares.

Tejara Capital Limited, through its managed fund Trefoil Select Funds SPC-Stylus SP, has reported beneficial ownership of 6,382,551 Class A Common Shares, representing 5.3% of the outstanding shares in Cardiol Therapeutics Inc.

Atlas Infrastructure Partners (UK) Ltd. and GIP Atlas Holdings Limited have filed an amendment to their Schedule 13G, correcting a previous misclassification of filing rule.

Several entities affiliated with Millennium Management have filed a Schedule 13G to confirm their beneficial ownership of Better Home & Finance Holding Company's Class A Common Stock.

RA Capital Management and its affiliates have reported beneficial ownership of 9.0% of BetterLife Pharma Inc.'s common shares, signaling a substantial investment.

RainForest Partners LLC has disclosed beneficial ownership of 2,298,851 shares, representing 8.404% of Cyabra, Inc.'s common stock, as of September 22, 2026.

The Hewlett Fund LP has reported beneficial ownership of 2,271,051 shares, representing 8.3% of Cyabra Inc.'s common stock, as of September 8, 2026.

PharmAla Biotech Holdings Inc. has disclosed beneficial ownership of 17.3% of Jupiter Neurosciences, Inc. common stock.

Leviticus Partners LP has filed a Schedule 13G, revealing beneficial ownership of 235,000 shares, representing 5.2% of Harvard Bioscience Inc.'s common stock.

ARC Group Limited and Abraham Cinta have jointly filed a Schedule 13G, reporting beneficial ownership of 2,739,152 ordinary shares, representing 18.26% of Black Titan Corp.

A Schedule 13G filing reveals updated beneficial ownership details for Advanced Biomed Inc. common stock.

Several Venrock-affiliated entities and individuals have jointly filed a Schedule 13G, reporting beneficial ownership of 5.6% of X4 Pharmaceuticals, Inc. common stock.

Several entities and an individual have entered into a joint filing agreement to disclose beneficial ownership of MarineMax Inc. common stock.

Thrivent Financial for Lutherans has reported beneficial ownership of 740,000 shares, representing 24.7% of the Mandatory Redeemable Preferred Shares, Series B, of RiverNorth Opportunities Fund, Inc.

Several Biotechnology Value Funds and Mark N. Lampert have filed a joint statement detailing their beneficial ownership of Tyra Biosciences, Inc. common stock.

Menachem Wagner has filed a Schedule 13G, reporting beneficial ownership of 9.9% of Nuran Wireless Inc.'s common shares, including shares held through controlled entities and potential shares from warrant exercises.

Frazier Life Sciences entities have filed a Schedule 13G, reporting beneficial ownership of Aclaris Therapeutics, Inc. common stock.

Konstantinos Konstantakopoulos and Longshaw Maritime Investments S.A. report beneficial ownership of 4.9% of Seanergy Maritime Holdings Corp. common stock.

Steven Blasnik has filed a Schedule 13G, reporting beneficial ownership of 5.09% of Cricut, Inc.'s Class A Common Stock through convertible Class B Shares.

A significant ownership stake of 8.6% in Arxis, Inc. Class A Common Stock is reported by the Gerald W. Simonson Revocable Trust Agreement.

MMCAP International Inc. SPC and MM Asset Management Inc. have jointly reported beneficial ownership of 1,285,000 units, representing 8.6% of Leader's Advantage Acquisition Corp.

Peter Moll has filed a Schedule 13G, disclosing beneficial ownership of 2,537,138 shares, representing 5.2% of the common stock of Werewolf Therapeutics, Inc.

Gregory Castaldo has filed a Schedule 13G, reporting beneficial ownership of 9.6% of Creatd, Inc.'s common stock.

General Atlantic, through various entities, has reported beneficial ownership of 3,201,131 shares, representing 6.8% of Korsana Biosciences' common stock, as of September 8, 2026.